Research breakdowns

What the studies actually found

Each breakdown summarises a body of published work, states the design and sample honestly, and separates what the data supports from what the marketing claims.

6 breakdowns matched

Journal of Orthopaedic Research and related models· 2024

BPC-157 in Tendon Healing: What the Animal Models Show

Across a series of rodent studies, BPC-157 consistently accelerated tendon repair following induced injury. The consistency is striking; the absence of human trials is the story.

Read the breakdown

Large-scale randomised outcome trials· 2024

GLP-1 Receptor Agonists: Cardiovascular Outcomes Beyond Weight Loss

Cardiovascular outcome trials moved GLP-1 agonists from weight-loss drugs to cardiovascular interventions. This is the strongest human evidence base of any compound in our library.

Read the breakdown

Endocrinology and clinical pharmacology studies· 2023

Ipamorelin: Selectivity and the Growth Hormone Pulse

Human and animal studies consistently show ipamorelin raising growth hormone without the cortisol, prolactin and appetite effects of earlier secretagogues. The hormonal effect is well characterised.

Read the breakdown

Cardiovascular regeneration studies· 2022

Thymosin Beta-4 and Cardiac Repair After Infarction

Animal models showed thymosin beta-4 improving cardiac function after induced infarction. The human work that followed used different formulations and produced mixed results.

Read the breakdown

Russian clinical and neuropharmacology literature· 2021

Semax and BDNF: Cognitive Effects in Human Trials

Small human trials report improvements in attention and memory alongside neuroprotective effects in stroke recovery. The BDNF mechanism is well supported in animals.

Read the breakdown

Telomerase and ageing research· 2020

Epithalamin and Telomere Length: Small Trials, Big Claims

Telomerase activation has been demonstrated in cultured human cells. The leap from that to clinical longevity benefit is where the evidence stops.

Read the breakdown

Our standard

We publish the limitations too

A breakdown that only reports positive findings is advertising. Every entry here states sample sizes, study design and where the evidence runs out.